D.E. Shaw & Co’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

D.E. Shaw & Co’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$5.19K	–	4789
2023 Q1	$5.19K	Hold	100,000	–	–	﹤0.01%	4309
2022 Q4	$510	Hold	100,000	–	–	﹤0.01%	4808
2022 Q3	$8K	Hold	100,000	–	–	﹤0.01%	4969
2022 Q2	$11K	Hold	100,000	–	–	﹤0.01%	5131
2022 Q1	$31K	Buy	+100,000	New	+$40.5K	﹤0.01%	5268

D.E. Shaw & Co's LVACW Position: Q2 2023 in Review

D.E. Shaw & Co sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 100,000 shares — an estimated $5.19K sold.

D.E. Shaw & Co first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $31K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

D.E. Shaw & Co reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
D.E. Shaw & Co sold 100,000 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $5.19K.
D.E. Shaw & Co first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
D.E. Shaw & Co's LAVA Medtech Acquisition Corp. Warrants position peaked at $31K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.